![Jennifer Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Simpson
Chief Executive Officer at
SUN BIOPHARMA INC
Net worth: - $ as of 2026-05-30
Profile
Dr. Jennifer K.
Simpson is a President, Chief Executive Officer & Director at Panbela Therapeutics, Inc. and a Lead Independent Director at Eagle Pharmaceuticals, Inc. She is on the Board of Directors at Panbela Therapeutics, Inc. and Eagle Pharmaceuticals, Inc. Dr. Simpson was previously employed as a Chairman by LadRx Corp., a President, Chief Executive Officer & Director by BGH Medical Products, a VP-Global Marketing & Oncology Brand by ImClone Systems, Inc., and a Product Director-Oncology Therapeutics Marketing by Centocor Ortho Biotech, Inc. She received her undergraduate degree from State University of New York at Buffalo, a graduate degree from Rochester Christian University and a doctorate degree from the University of Pittsburgh.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LADRX CORPORATION 0.01% | 2025-03-27 | 25 ( 0.01% ) | 0 $ | 2026-05-30 |
Jennifer Simpson active positions
| Companies | Position | Start |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Director/Board Member | 2019-08-27 |
| SUN BIOPHARMA INC | Chief Executive Officer | 2020-07-15 |
Former positions of Jennifer Simpson
| Companies | Position | End |
|---|---|---|
| LADRX CORPORATION | Chairman | 2025-07-27 |
| DELCATH SYSTEMS, INC. | Chief Executive Officer | 2020-05-31 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 2010-12-31 |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Sales & Marketing | 2007-12-31 |
Training of Jennifer Simpson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
49
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
LadRx Corp.
 LadRx Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development oncology company | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Panbela Therapeutics, Inc.
 Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
- Stock Market
- Insiders
- Jennifer Simpson
